Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03203174 · ClinicalTrials.gov registry record · Phase 1
The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT03203174 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 13 participants.
The verdict
NCT03203174, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
Hyperhidrosis or sweating of palms results from the overactivity of sweat glands and leads to psychosocial impairment with reduction in quality of life in those that are affected. Injection of botulinum toxin has been shown to be effective in reducing the symptoms of hyperhidrosis with associated improvement in quality of life, but is usually very painful. Microneedles are a different modality for transdermal drug penetration without the pain. This study aims to understand if botulinum toxin A can be delivered topically after microneedle pretreatment in hopes of developing a minimally painful treatment protocol for treatment of palmar hyperhidrosis.
Interventions
- OTHER Saline
- DRUG Botulinum Toxin Type A
- DEVICE Microneedle
- DEVICE Sham Microneedle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03203174
The ClinicalTrials.gov registry entry for NCT03203174 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Saline is the first listed.
NCT03203174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03203174 about?
NCT03203174 is a clinical study titled "The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis". Hyperhidrosis or sweating of palms results from the overactivity of sweat glands and leads to psychosocial impairment with reduction in quality of life in those that are affected. Injection of botulinum toxin has been shown to be effective in reducing the symptoms of hyperhidrosis with associated im...
What is the current status of trial NCT03203174?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2015-01. Estimated completion is 2016-08-02.
What interventions are being tested in trial NCT03203174?
The interventions under investigation include: Saline (OTHER), Botulinum Toxin Type A (DRUG), Microneedle (DEVICE), Sham Microneedle (DEVICE).
Who is sponsoring clinical trial NCT03203174?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.